What's Going On With Allurion Stock On Wednesday?

Benzinga02-25

Allurion Technologies, Inc. (NYSE:ALUR) shares fell on Wednesday after the gastric balloon maker announced a discounted warrant exercise, raising concerns about dilution. On Tuesday, Allurion said it ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614392100?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/02/25/Stock-Market-Analysis-With-Candlestick-C.jpeg?optimize=medium&dpr=2&auto=webp&width=260","is_english":true,"pubTime":"2026-02-25 23:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614392100","market":"sh","top_or_hot":-1,"title":"What's Going On With Allurion Stock On Wednesday?","media":"Benzinga","content":"<div>\n<p>Allurion Technologies, Inc. (NYSE:ALUR) shares fell on Wednesday after the gastric balloon maker announced a discounted warrant exercise, raising concerns about dilution.\nOn Tuesday, Allurion said it ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/02/50853990/whats-going-on-with-allurion-stock-on-wednesday\">Source Link</a>\n\n</div>\n","source":"benzinga_hot_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's Going On With Allurion Stock On Wednesday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's Going On With Allurion Stock On Wednesday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-25 23:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/02/50853990/whats-going-on-with-allurion-stock-on-wednesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Allurion Technologies, Inc. (NYSE:ALUR) shares fell on Wednesday after the gastric balloon maker announced a discounted warrant exercise, raising concerns about dilution.\nOn Tuesday, Allurion said it ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/02/50853990/whats-going-on-with-allurion-stock-on-wednesday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4192","symbol_name":"特殊消费者服务","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/02/50853990/whats-going-on-with-allurion-stock-on-wednesday","article_id":"2614392100","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/02/25/Stock-Market-Analysis-With-Candlestick-C.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/markets/equities/26/02/50853990/whats-going-on-with-allurion-stock-on-wednesday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614392100","pubTimestamp":1772033940,"columns":[],"sourceInfo":{"source_id":"benzinga_hot_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Allurion shares slipped after it priced a discounted warrant exercise expected to raise about $3 million and add potential dilution.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4192":"特殊消费者服务","ALUR":"ALLURION TECHNOLOGIES","BK4217":"自存仓储房地产信托","SMA":"Smartstop Self Storage REIT Inc"},"translate_title":"周三Allurion股票发生了什么？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SMA":1,"ALUR":1},"content_text":"Allurion Technologies, Inc. (NYSE:ALUR) shares fell on Wednesday after the gastric balloon maker announced a discounted warrant exercise, raising concerns about dilution.\nOn Tuesday, Allurion said it will immediately exercise certain outstanding warrants at a reduced price of $1.15 per share. The move generates approximately $3 million in gross proceeds. The company entered into a definitive agreement covering about 2.66 million shares, with closing expected on or around Feb. 25.\nAs part of the transaction, Allurion also agreed to file a resale registration statement with the SEC covering up to 5.32 million shares underlying new warrants issued in the private placement, also exercisable at $1.15 per share.\nThe broader market and technology sector both rose in the prior session. This suggests that company-specific factors drove the stock's decline.\nThe latest development follows the company's U.S. Food and Drug Administration premarket approval (PMA) application for the Allurion Gastric Balloon System on Feb. 23, which features the Allurion Smart Capsule.\n\"Today's approval is a watershed moment for Allurion and for obesity care in the United States,\" said Dr. Shantanu Gaur, founder and CEO. \"Our goal is to deliver patients metabolically healthy weight loss by helping them lose weight, keep it off, and maintain muscle.\"\nGaur added that the Allurion Smart Capsule offers \"a safe and effective alternative to GLP-1s and bariatric surgery,\" and said it \"should become a standard tool in the comprehensive treatment of obesity in the United States.\"\nThe stock is currently trading 8.5% below its 20-day simple moving average (SMA) and 12.3% below its 100-day SMA, suggesting a bearish trend in the short to medium term. Shares have decreased by 68% over the past 12 months and are currently positioned closer to their 52-week lows than highs.\nThe RSI is at 50.00, indicating a neutral position, while the MACD is at 0.00, below its signal line at 0.10, suggesting bearish pressure on the stock. The combination of neutral RSI and bearish MACD indicates mixed momentum.\nNYSE:ALUR is slated to provide its next financial update on March 25, 2026.\nAnalyst Consensus & Recent Actions: The stock carries a Buy Rating with an average price target of $48.50. Recent analyst moves include:\nALUR Price Action: Allurion Technologies shares were down 2.21% at $1.33 during premarket trading on Wednesday, according to Benzinga Pro data.\nImage: Shutterstock\nThis content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.\nTo add Benzinga News as your preferred source on Google, click here.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614392100","isCrawlerRequest":true}